| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > The Innovation Journey-A Roadmap |
|
Just Other Articles - The Innovation Journey-A Roadmap
As with any journey it is always a good plan to get directions and know where you are going before you start. This ensures you According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product of knowing the fastest route and revealing where the roadblocks may be. The innovation journey, much like any driving excursio ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in n, also requires an understanding of where you want to go, the roadblocks you may hit and how long it could take. So before you lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. get in the car and start your engine, here are some things to consider on the Innovation journey. First, innovation must be f here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ully aligned with your marketing strategies and objectives. Sounds obvious, right? But many marketers today undertake product i d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro novation simply because they think change will provide an added benefit. This is not always a good thing, nor is it always gree ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ted at the shelf with applause. Marketers oftentimes fail to properly align innovation with actual consumer needs, and this for easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ces their strategy right off the road and into a ditch. Innovation in product development and packaging design must be fully i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ntegrated; not separate. If not, your innovation strategy, like your brand planning, will never get out of the garage. More tha and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ n anything, if you focus on being connected with the emerging needs and desires of consumers, your marketing strategy will unlo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi k the clues on how innovation will lead to your product standing out on the shelf. Another important element is understanding ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a how consumers shop your category. How many of you have ever watched or observed consumers at point of purchase? (And no, readin dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod g research on how consumers shop doesn't count). You have to see how they move and interact at the point of purchase. You have cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin to know the environment your products occupy and realize what other forces are around it. Is it cluttered, poorly lit, noisy, c tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ramped, or crowded? You must use these insights to challenge the norms to achieve distinction. That's real innovation. Anything t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel else is just some low-fat or reduced carb version of innovation. So understanding what I call 'The Moment of Intimacy', that b ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rief two-second moment where consumers choose between brands and make a purchase decision at the shelf, is not only critical, i y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products t is key to staying competitively alive. Innovation must keep the consumer's needs in mind And innovation must benefit your co . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nsumer by making a direct impact on their purchasing behavior. So remember, when planning any innovation trip, have a roadmap b elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip efore you start, and carefully consider how it makes sense to your consumers. Otherwise you will never get out of your driveway tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:A Basic Introduction to Accounts Receivables Recruiters for MSN or Data Miners? Confidence Is Critical to YOUR Success....
|